Boston Scientific EVP exercises 1,802 RSUs

Boston Scientific EVP Padraig Andrew O'Connor reported routine equity compensation activity involving restricted stock units.

Rhea-AI Filing Summary

Boston Scientific EVP Padraig Andrew O'Connor reported routine equity compensation activity involving restricted stock units. On May 2, 2026, he exercised awards covering 1,802 restricted stock units, receiving the same number of shares of Boston Scientific common stock.

To satisfy tax obligations related to this vesting, 872 common shares were disposed of at $56.50 per share through a tax-withholding transaction, which is not an open-market sale. Following these transactions, O'Connor directly holds 7,024 shares of common stock.

Insider Trade Summary

1,802 shares exercised/converted

Exercise 3 txns

Insider O'Connor Padraig Andrew

Role EVP, Global Operations

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,802	$0.00	$0.00
Exercise	Common Stock	1,802	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	872	$56.50	$49K

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 7,024 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. F2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.

Key Figures

RSUs exercised: 1,802 units/shares Tax-withholding shares: 872 shares Tax-withholding price: $56.50 per share +1 more

4 metrics

RSUs exercised 1,802 units/shares Restricted stock units converted to common stock on May 2, 2026

Tax-withholding shares 872 shares Common shares disposed in tax-withholding transaction at $56.50

Tax-withholding price $56.50 per share Value applied to 872-share tax-withholding disposition

Shares held after transactions 7,896 shares Direct common stock holdings following Form 4 transactions

Key Terms

Restricted Stock Units, tax-withholding disposition, derivative security, Common Stock

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents the Company's commitment to issue one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"Payment of exercise price or tax liability by delivering securities"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Common Stock financial

"Shares of common stock will be issued to the reporting person in four equal annual installments"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Boston Scientific (BSX) EVP Padraig O'Connor report in this Form 4?

Padraig O'Connor reported routine equity compensation activity. He exercised 1,802 restricted stock units into common stock and had 872 shares withheld to cover taxes, ending with 7,896 Boston Scientific common shares held directly.

How many Boston Scientific (BSX) shares did the EVP acquire through RSU vesting?

The EVP acquired 1,802 shares of Boston Scientific common stock through the exercise of restricted stock units. Each unit represented a commitment to issue one share, converting on May 2, 2026, as part of his long-term equity compensation package.

Were any of the Boston Scientific (BSX) shares in this Form 4 sold on the open market?

No open-market sale is reported. The 872-share disposition is labeled as a tax-withholding transaction, meaning shares were withheld to pay tax obligations on vested awards, rather than being sold at the insider’s discretion in the open market.

How many Boston Scientific (BSX) shares does the EVP hold after these transactions?

After the reported transactions, Padraig O'Connor directly holds 7,896 shares of Boston Scientific common stock. This figure reflects his position following the RSU exercise and the 872-share tax-withholding disposition disclosed in the Form 4 filing.

What price per share was used for the Boston Scientific (BSX) tax-withholding transaction?

The 872 shares used for tax withholding were valued at $56.50 per share. This price is applied within the tax-related disposition to cover the exercise price or tax liability arising from the vesting of restricted stock unit awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 05:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Connor Padraig Andrew

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/02/2026		M		1,802	A	$0.0000(1)	7,896	D
Common Stock	05/02/2026		F		872	D	$56.5	7,024	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/02/2026		M			1,802	(2)	05/02/2026(2)	Common Stock	1,802	$0.0000	0.0000	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)